AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms

Saved in:

Bibliographic Details
Main Authors:	Beitzen-Heineke, Antonia (Author) , Berenbrok, Nikolaus (Author) , Waizenegger, Jonas S. (Author) , Paesler, Sarina (Author) , Gensch, Victoria (Author) , Udonta, Florian (Author) , Vargas Delgado, Maria Elena (Author) , Engelmann, Janik (Author) , Hoffmann, Friederike (Author) , Schafhausen, Philippe (Author) , Amsberg, Gunhild von (Author) , Riecken, Kristoffer (Author) , Beumer, Niklas (Author) , Imbusch, Charles (Author) , Lorens, James (Author) , Fischer, Thomas (Author) , Pantel, Klaus (Author) , Bokemeyer, Carsten (Author) , Ben-Batalla, Isabel (Author) , Loges, Sonja (Author)
Format:	Article (Journal)
Language:	English
Published:	2021
In:	HemaSphere Year: 2021, Volume: 5, Issue: 9, Pages: 1-13
ISSN:	2572-9241
Online Access:	Resolving-System, kostenfrei: https://journals.lww.com/hemasphere/Fulltext/2021/09000/AXL_Inhibition_Represents_a_Novel_Therapeutic.2.aspx
Author Notes:	Antonia Beitzen-Heineke, Nikolaus Berenbrok, Jonas Waizenegger, Sarina Paesler, Victoria Gensch, Florian Udonta, Maria Elena Vargas Delgado, Janik Engelmann, Friederike Hoffmann, Philippe Schafhausen, Gunhild von Amsberg, Kristoffer Riecken, Niklas Beumer, Charles D. Imbusch, James Lorens, Thomas Fischer, Klaus Pantel, Carsten Bokemeyer, Isabel Ben-Batalla, Sonja Loges

Description
Physical Description:	Online Resource
ISSN:	2572-9241

Similar Items